John Stone, MD, MPH

Stone is professor of medicine at Harvard Medical School and the Edward A Fox Chair in Medicine at the Massachusetts General Hospital. He has treated IgG4-related disease (IgG4-RD) since its emergence in recent years and is passionate about educating patients and fellow healthcare providers (HCPs) about the indolent and systemic nature of this disease.

Articles by John Stone, MD, MPH

INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH

ByJohn Stone, MD, MPH

November 11th 2026

John Stone, MD, MPH, discusses INDIGO open-label extension data showing durable flare control with obexelimab in IgG4-related disease at ACR 2026.

Achieving GC-Free IgG4-Related Disease Remission With Rilzabrutinib, with John Stone, MD, MPH

ByJohn Stone, MD, MPH

July 9th 2025

Rilzabrutinib shows promising remission rates in IgG4-related disease with minimal glucocorticoid use, offering a safer oral treatment option.

New ICD-10 Code is An Important Milestone for Rare Disease Patients

ByJohn Stone, MD, MPH

October 29th 2023

The introduction of an ICD-10 code specific to IgG4-Related Disease offers a promising opportunity to revolutionize patient care, enable more accurate diagnoses, and improve outcomes.